Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded, Comparator Controlled, Cross-over Clinical Trial to Assess the Pharmacokinetic Profile of Three Coenzyme Q10 Formulations in Healthy Adults

NCT07255079 is registered in ClinicalTrials.gov with 3i Solutions as lead sponsor.

NCT NCT07255079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07255079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded, Comparator Controlled, Cross-over Clinical Trial to Assess the Pharmacokinetic Profile of Three Coenzyme Q10 Formulations in Healthy Adults
Lead sponsor
3i Solutions
Phase
Not applicable
Overall status
Completed
Start date
April 3, 2026
Completion date
June 29, 2026
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioavailability heathy volunteers, pharmacokinetic parameters